KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Change in Account Payables: 2009-2024

Historic Change in Account Payables for Jazz Pharmaceuticals (JAZZ) over the last 16 years, with Dec 2024 value amounting to -$20.1 million.

  • Jazz Pharmaceuticals' Change in Account Payables rose 587.55% to $62.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.7 million, marking a year-over-year increase of 362.33%. This contributed to the annual value of -$20.1 million for FY2024, which is 309.03% down from last year.
  • As of FY2024, Jazz Pharmaceuticals' Change in Account Payables stood at -$20.1 million, which was down 309.03% from $9.6 million recorded in FY2023.
  • Over the past 5 years, Jazz Pharmaceuticals' Change in Account Payables peaked at $57.0 million during FY2021, and registered a low of -$20.1 million during FY2024.
  • Over the past 3 years, Jazz Pharmaceuticals' median Change in Account Payables value was -$11.2 million (recorded in 2022), while the average stood at -$7.2 million.
  • As far as peak fluctuations go, Jazz Pharmaceuticals' Change in Account Payables slumped by 496.96% in 2020, and later soared by 401.14% in 2021.
  • Over the past 5 years, Jazz Pharmaceuticals' Change in Account Payables (Yearly) stood at -$18.9 million in 2020, then surged by 401.14% to $57.0 million in 2021, then slumped by 119.69% to -$11.2 million in 2022, then surged by 185.55% to $9.6 million in 2023, then tumbled by 309.03% to -$20.1 million in 2024.